it is worth exploring its application in the treatment of MDS. Compared to CAR-T cell therapy, CAR-NK cell therapy allows unlimited use of allogeneic NK cell sources without concern for the ...

Forward steps are being made in HNSCC, and the first patient with MDS has been treated with iadademstat/azacitidine.

The investigational immunotherapy bexmarilimab has been granted orphan drug designation from the FDA for patients with ...

TScan Therapeutics is developing TSC-101 and multiplex TCR-Ts for cancer treatment. See why TCRX stock holds potential with ...

relapsed MDS in 2020 and as a first-line therapy last year. The filing is based mainly on results from the phase 3 IMerge trial – also known as Study MDS3001 - which showed that around 40% of ...

Feb. 4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in ... How Healthy Stem Cells Turn Into Or ...

Mar. 4, 2025 — A vivid new image is taking shape in the world of cell biology: Imagine bacteria adhering to the surface of a cell, perhaps at the site of an injury or wound. In response ...

Q4 2024 Earnings Call Transcript March 4, 2025 Rigel Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.8, expectations were $0.3. Operator: Greetings, and welcome to Rigel ...

Q4 2024 Earnings Conference Call March 4, 2025 4:30 PM ET. Company Participants. Ray Furey - Executive Vice President, General Counsel & ...

This advertisement has not loaded yet, but your article continues below. Adulting is overrated. At least that’s the idea behind one of the key design trends forecasted by Pinterest for 2025; it ...

Black women with chronic myeloid leukemia face unique challenges when it comes to diagnosis, treatment, and overall disease ...